Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study - PubMed (original) (raw)
Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study
Sophie A Vreeburg et al. Arch Gen Psychiatry. 2009 Jun.
Abstract
Context: There is a central belief that depression is associated with hyperactivity of the hypothalamic-pituitary-adrenal axis, resulting in higher cortisol levels. However, results are inconsistent.
Objective: To examine whether there is an association between depression and various cortisol indicators in a large cohort study.
Design, setting, and participants: Data are from 1588 participants of the Netherlands Study of Depression and Anxiety who were recruited from the community, general practice care, and specialized mental health care. Three groups were compared: 308 control subjects without psychiatric disorders, 579 persons with remitted (no current) major depressive disorder (MDD), and 701 persons with a current MDD diagnosis, as assessed using the DSM-IV Composite International Diagnostic Interview.
Main outcome measures: Cortisol levels were measured in 7 saliva samples to determine the 1-hour cortisol awakening response, evening cortisol levels, and cortisol suppression after a 0.5-mg dexamethasone suppression test.
Results: Both the remitted and current MDD groups showed a significantly higher cortisol awakening response compared with control subjects (effect size [Cohen d] range, 0.15-0.25). Evening cortisol levels were higher among the current MDD group at 10 pm but not at 11 pm. The postdexamethasone cortisol level did not differ between the MDD groups. Most depression characteristics (severity, chronicity, symptom profile, prior childhood trauma) were not associated with hypothalamic-pituitary-adrenal axis activity except for comorbid anxiety, which tended to be associated with a higher cortisol awakening response. The use of psychoactive medication was generally associated with lower cortisol levels and less cortisol suppression after dexamethasone ingestion.
Conclusions: This large cohort study shows significant, although modest, associations between MDD and specific hypothalamic-pituitary-adrenal axis indicators. Because a higher cortisol awakening response was observed among both subjects with current MDD and subjects with remitted MDD, this may be indicative of an increased biological vulnerability for depression.
Similar articles
- Salivary cortisol levels in persons with and without different anxiety disorders.
Vreeburg SA, Zitman FG, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Hoogendijk WJ, Smit JH, Penninx BW. Vreeburg SA, et al. Psychosom Med. 2010 May;72(4):340-7. doi: 10.1097/PSY.0b013e3181d2f0c8. Epub 2010 Feb 26. Psychosom Med. 2010. PMID: 20190128 - Salivary cortisol levels and the 2-year course of depressive and anxiety disorders.
Vreeburg SA, Hoogendijk WJ, DeRijk RH, van Dyck R, Smit JH, Zitman FG, Penninx BW. Vreeburg SA, et al. Psychoneuroendocrinology. 2013 Sep;38(9):1494-502. doi: 10.1016/j.psyneuen.2012.12.017. Epub 2013 Jan 11. Psychoneuroendocrinology. 2013. PMID: 23313277 - Increased cortisol awakening response was associated with time to recurrence of major depressive disorder.
Hardeveld F, Spijker J, Vreeburg SA, Graaf RD, Hendriks SM, Licht CM, Nolen WA, Penninx BW, Beekman AT. Hardeveld F, et al. Psychoneuroendocrinology. 2014 Dec;50:62-71. doi: 10.1016/j.psyneuen.2014.07.027. Epub 2014 Aug 12. Psychoneuroendocrinology. 2014. PMID: 25179322 - The cortisol awakening response--applications and implications for sleep medicine.
Elder GJ, Wetherell MA, Barclay NL, Ellis JG. Elder GJ, et al. Sleep Med Rev. 2014 Jun;18(3):215-24. doi: 10.1016/j.smrv.2013.05.001. Epub 2013 Jul 5. Sleep Med Rev. 2014. PMID: 23835138 Review. - Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis.
Zorn JV, Schür RR, Boks MP, Kahn RS, Joëls M, Vinkers CH. Zorn JV, et al. Psychoneuroendocrinology. 2017 Mar;77:25-36. doi: 10.1016/j.psyneuen.2016.11.036. Epub 2016 Dec 8. Psychoneuroendocrinology. 2017. PMID: 28012291 Review.
Cited by
- What can the psychoneuroimmunology of yoga teach us about depression's psychopathology?
Chiarpenello C, Brodmann K. Chiarpenello C, et al. Brain Behav Immun Health. 2024 Sep 30;42:100877. doi: 10.1016/j.bbih.2024.100877. eCollection 2024 Dec. Brain Behav Immun Health. 2024. PMID: 39430877 Free PMC article. - The effects of shared, depression-specific, and anxiety-specific internalizing symptoms on negative and neutral episodic memories following post-learning sleep.
Niu X, Utayde MF, Sanders KEG, Cunningham TJ, Zhang G, Kensinger EA, Payne JD. Niu X, et al. Cogn Affect Behav Neurosci. 2024 Aug 13. doi: 10.3758/s13415-024-01209-5. Online ahead of print. Cogn Affect Behav Neurosci. 2024. PMID: 39138784 - Endocrine-Disrupting Chemicals Exposure and Neurocognitive Function in the General Population: A Community-Based Study.
Su FC, Wei YC, Sun CY, Hsu HJ, Lee CC, Chen YT, Pan HC, Hsu CK, Liu YA, Chen CY. Su FC, et al. Toxics. 2024 Jul 17;12(7):514. doi: 10.3390/toxics12070514. Toxics. 2024. PMID: 39058166 Free PMC article. - Depressive symptoms are not associated with clinically important levels of digital home blood pressure in the electronic Framingham Heart Study.
Lee J, Wang X, Liu C, Pathiravasan CH, Benjamin EJ, McManus DD, Murabito JM. Lee J, et al. Cardiovasc Digit Health J. 2024 Feb 1;5(2):50-58. doi: 10.1016/j.cvdhj.2024.01.001. eCollection 2024 Apr. Cardiovasc Digit Health J. 2024. PMID: 38765623 Free PMC article. - Serotonin effects on human iPSC-derived neural cell functions: from mitochondria to depression.
Cardon I, Grobecker S, Jenne F, Jahner T, Rupprecht R, Milenkovic VM, Wetzel CH. Cardon I, et al. Mol Psychiatry. 2024 Sep;29(9):2689-2700. doi: 10.1038/s41380-024-02538-0. Epub 2024 Mar 26. Mol Psychiatry. 2024. PMID: 38532010 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources